Showing results (81-90 of 167) with videos related to

Sort By:
Pageof 17
Molecular Cancer Therapeutics|June 11, 2009
The telomerase template antagonist GRN163L alters MDA-MB-231 breast cancer cell morphology, inhibits growth, and augments the effects of paclitaxelErin M Goldblatt, Erin R Gentry, Melanie J Fox, et al.
Stem Cell Reviews and Reports|February 25, 2010
The effect of telomerase template antagonist GRN163L on bone-marrow-derived rat mesenchymal stem cells is reversible and associated with altered expression of cyclin d1, cdk4 and cdk6Zeynep Tokcaer-Keskin, Zeliha G Dikmen, Fatma Ayaloglu-Butun, et al.
Khirurgiia|December 12, 2019
[Transoral endoscopic thyroid surgery]S E Gryaznov, A M Shulutko, G G Melkonyan, et al.
Urologiia (Moscow, Russia : 1999)|March 2, 2017
[Use of flexible needles and ways to control their placement in robot-assisted prostate brachytherapy]A V Lopota, N A Gryaznov, K Yu Senchik, et al.
Nucleosides, Nucleotides & Nucleic Acids|December 11, 2007
Oligonucleotide conjugate GRN163L targeting human telomerase as potential anticancer and antimetastatic agentSergei M Gryaznov, Shalmica Jackson, Gunnur Dikmen, et al.
World Journal of Surgery|June 22, 2019
Reporting Quality of Journal Abstracts for Surgical Randomized Controlled Trials Before and After the Implementation of the CONSORT Extension for AbstractsBenjamin Speich, Kimberly A Mc Cord, Arnav Agarwal, et al.
Urologiia (Moscow, Russia : 1999)|March 2, 2017
[Brachytherapy needle steering using intra-tissue real-time ultrasound 3d visualization]N A Gryaznov, K Y Senchik, G S Kireeva, et al.
Scientific Reports|September 28, 2020
Atomic, electronic and magnetic structure of an oxygen interstitial in neutron-irradiated Al2O3 single crystalsV Seeman, A Lushchik, E Shablonin, et al.
Virology|October 1, 2003
An oligonucleotide complementary to the SL-B1 domain in the 3'-end of the minus-strand RNA of the hepatitis C virus inhibits in vitro initiation of RNA synthesis by the viral polymeraseSandrine Reigadas, Michel Ventura, Marie-Line Andreola, et al.
Neuro-Oncology|February 22, 2008
New therapeutic approach for brain tumors: Intranasal delivery of telomerase inhibitor GRN163Rintaro Hashizume, Tomoko Ozawa, Sergei M Gryaznov, et al.
Pageof 17